Ermanno Puxeddu Selected Research

Adrenal Cortex Hormones (Corticosteroids)

2/2022	Synergy across the drugs approved for the treatment of asthma.
11/2021	Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
4/2021	Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review.
1/2020	Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review.
1/2018	Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study.
1/2018	Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis.
2/2016	Interaction between corticosteroids and muscarinic antagonists in human airways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ermanno Puxeddu Research Topics

Disease

19	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 01/2013
8	Asthma (Bronchial Asthma) 02/2022 - 01/2016
4	Dyspnea (Shortness of Breath) 10/2021 - 12/2013
4	Idiopathic Pulmonary Fibrosis 03/2019 - 06/2014
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 12/2013
2	Pneumonia (Pneumonitis) 02/2022 - 04/2021
2	Hypoxia (Hypoxemia) 10/2021 - 12/2013
2	Inflammation (Inflammations) 10/2019 - 01/2018
2	Chronic Disease (Chronic Diseases) 10/2019 - 01/2017
2	Disease Progression 01/2018 - 10/2009
2	Pulmonary Hypertension 01/2018 - 06/2014
1	Post-Acute COVID-19 Syndrome 02/2023
1	Invasive Fungal Infections 01/2019
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018
1	Hypersensitivity (Allergy) 05/2017
1	Hemochromatosis (Bronze Diabetes) 02/2015
1	Fibrosis (Cirrhosis) 02/2015
1	Hemorrhage 06/2014

Drug/Important Bio-Agent (IBA)

7	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 02/2016
3	Muscarinic AntagonistsIBA 11/2021 - 01/2017
3	Formoterol Fumarate (Oxis)FDA Link 04/2021 - 10/2015
3	IronIBA 01/2018 - 06/2014
2	Oxygen (Dioxygen)IBA 10/2021 - 12/2013
2	Budesonide (Pulmicort)FDA LinkGeneric 04/2021 - 01/2016
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2021 - 01/2018
2	Expectorants (Mucolytics)IBA 05/2019 - 01/2018
2	AntioxidantsIBA 05/2019 - 01/2018
2	AntigensIBA 01/2019 - 10/2009
2	Bronchodilator Agents (Bronchodilators)IBA 01/2018 - 04/2016
1	Drug CombinationsIBA 02/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2022
1	vilanterolIBA 04/2021
1	GSK573719IBA 04/2021
1	Beclomethasone (Beclometasone)FDA Link 04/2021
1	fluticasone furoate FDA Link 04/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	velsecoratIBA 01/2020
1	GW870086XIBA 01/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	2,2,2- trifluoro- N- (1- ((1- (4- fluorophenyl)- 1H- indazol- 5- yl)oxy)- 1- (3- methoxyphenyl)- 2- propanyl)acetamideIBA 01/2020
1	Receptor for Advanced Glycation End ProductsIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	erdosteineIBA 05/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 05/2019
1	Carbocysteine (S-Carboxymethylcysteine)IBA 05/2019
1	pirfenidoneIBA 03/2019
1	galactomannanIBA 01/2019
1	GoldIBA 01/2018
1	ciclesonide FDA Link 01/2018
1	RoflumilastIBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	CytokinesIBA 01/2018
1	ChemokinesIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Vasopressins (Vasopressin)IBA 05/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 05/2017
1	LatexIBA 05/2017
1	tiotropium-olodaterolIBA 04/2016
1	Tiotropium Bromide (Spiriva)FDA Link 04/2016
1	olodaterolIBA 04/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	Coloring Agents (Dyes)IBA 02/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015
1	Malondialdehyde (Propanedial)IBA 02/2015
1	SmokeIBA 06/2014
1	indacaterolIBA 01/2013

Therapy/Procedure

13	Therapeutics 02/2023 - 01/2013
3	Nebulizers and Vaporizers (Inhaler) 11/2019 - 01/2016
2	Precision Medicine 01/2018 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2024
1	Biological Therapy 01/2018
1	Obstetric Surgical Procedures 05/2017
1	Polypharmacy 01/2017
1	Duration of Therapy 01/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Dry Powder Inhalers 01/2016
1	Metered Dose Inhalers (Metered Dose Inhaler) 01/2016